LINTS, a non-masking low-intensity noise tuned to each patient’s tinnitus frequency, produced statistically significant but modest reductions in tinnitus burden in a phase II clinical trial. Improvements were confined to the treatment-only group, with high individual variability and strong dependence on precise acoustic fitting.